Mai Capital Management Novartis Ag Transaction History
Mai Capital Management
- $15.6 Billion
- Q3 2025
A detailed history of Mai Capital Management transactions in Novartis Ag stock. As of the latest transaction made, Mai Capital Management holds 29,788 shares of NVS stock, worth $3.92 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
29,788
Previous 22,468
32.58%
Holding current value
$3.92 Million
Previous $2.5 Million
52.56%
% of portfolio
0.02%
Previous 0.02%
Shares
27 transactions
Others Institutions Holding NVS
# of Institutions
1,618Shares Held
136MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...